Physician

Amy Raj Patel, M.D.

According to 2025 Medicare claims, Amy Patel, M.D. (NPI: 1225439748) practices nephrology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is JERSEY COAST NEPHROLOGY AND HYPERTENSION ASSOCIATES LLC (NPI: 1740204494; TIN: 201775529) and primary practice location at 08724-7732. Patel is affiliated with the St. Luke's Medicare ACO (ACO ID: A3560) and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 792 traditional Medicare patients, billed 2,320 HCPCS/CPT codes, and received $245,187 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,192 prescription claims across 225 beneficiaries totaling $142,840 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2020 DME data shows 12 claims. Open Payments data shows 51 records totaling $965. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $46,236 to $245,187. Similarly, Part D prescription costs have moved sharply higher in recent years, from $8,717 to $142,840. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	261	593	$46,236
2017	249	739	$57,074
2018	482	1,081	$89,083
2019	637	1,789	$152,865
2020	800	2,983	$312,479
2021	772	2,618	$294,447
2022	806	2,538	$268,775
2023	676	1,802	$197,037
2024	792	2,320	$245,187

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	51	144	$8,717
2017	87	170	$8,253
2018	91	200	$10,838
2019	63	128	$12,131
2020	74	370	$14,547
2021	104	582	$19,759
2022	175	895	$69,675
2023	179	896	$74,173
2024	225	1,192	$142,840

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	24	$744
2018	N/R	39	$1,438
2019	N/R	53	$1,652
2020	N/R	12	$44
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	233	243	$142
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$133
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	299	698	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	190	440	$92
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	290	543	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	66	3,964	$73,242
Jardiance	Empagliflozin	15	870	$16,665
Lokelma	Sodium Zirconium Cyclosilicate	33	1,064	$13,860
Dapagliflozin	Dapagliflozin Propanediol	13	428	$7,917
Potassium Citrate Er	Potassium Citrate	47	2,920	$3,886

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$965	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy Raj Patel, M.D.?

Tedicare shows public-source Medicare data for Amy Raj Patel, M.D. (NPI 1225439748), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Raj Patel, M.D. have ACO affiliation data?

Amy Raj Patel, M.D. is shown with ACO affiliation data for St. Luke's Medicare ACO (MSSP, ACO ID A3560) and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Amy Raj Patel, M.D.?

Amy Raj Patel, M.D. is linked to JERSEY COAST NEPHROLOGY AND HYPERTENSION ASSOCIATES LLC (billing NPI 1740204494) in the available physician profile data.

Does Amy Raj Patel, M.D. have Open Payments data?

Amy Raj Patel, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.